Message Image  

Join ACRP

Welcome to the Online Community!

Network. Learn. Teach. Share. Collaborate.

Your go-to place to connect and collaborate with thousands of ACRP members.  Get in touch with colleagues and share best practices, get answers to challenging questions, and network with like-minded professionals.  Open to ACRP members only.

Get Started

Latest Discussions

Clinical Research News

  • The U.S. Food and Drug Administration today approved a new balloon device to treat obesity without the need for invasive surgery. The ReShape Integrated Dual Balloon System (ReShape Dual Balloon) is intended to facilitate weight loss in obese adult patients. The device likely works by occupying space...
  • The U.S. Food and Drug Administration today approved Praluent (alirocumab) injection, the first cholesterol-lowering treatment approved in a new class of drugs known as proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitors.
  • The U.S. Food and Drug Administration today approved Daklinza (daclatasvir) for use with sofosbuvir to treat hepatitis C virus (HCV) genotype 3 infections. Daklinza is the first drug that has demonstrated safety and efficacy to treat genotype 3 HCV infections without the need for co-administration of...

New Documents Add Document

Follow ACRP

LinkedInFacebookTwitterYouTube

 


Most Active Members

One moment, processing...